The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype

被引:33
|
作者
Trembath, Dimitri
Ervin, John F.
Broom, Lucy
Szymanski, Mari
Welsh-Bohmer, Kathleen
Pieper, Carl
Hulette, Christine M.
机构
[1] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21218 USA
[3] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease (AD); cerebral amyloid angiopathy (CAA); ApoE; amyloid beta (A beta); cerebral arterioles;
D O I
10.1007/s00401-006-0162-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We performed a comparative study to assess cerebral amyloid angiopathy and ApoE genotype in cases of Alzheimer's disease (AD). Ten ApoE 3,3 and ten ApoE 4,4 AD brains, as well as ten normal control brains, were selected after matching for age, sex, and duration of disease. Sections of middle frontal and inferior parietal cortex including white matter sections were stained with an antibody against amyloid beta (A beta), and extensive analysis of arteriolar AP deposition was performed using digital image analysis. Quantification of the staining revealed a larger cross-section of arteriolar walls occupied by AP in ApoE 4,4 and ApoE 3,3 AD subjects compared to controls. Our results show A beta deposition in gray matter and white matter arterioles was predominantly found in ApoE 4,4 brains and, overall, A beta deposition was greatest in these cases. This observation implies that there is greater vascular amyloid deposition (particularly in the white matter arterioles) in ApoE 4,4 AD individuals compared to ApoE 3,3 AD. These observations may give insight into the etiology behind the increased risk for AD associated with the ApoE-epsilon 4 allele and the pathogenesis of vascular A beta deposition.
引用
下载
收藏
页码:23 / 31
页数:9
相关论文
共 50 条
  • [21] Influence of the ApoE genotype on serum APOE levels in Alzheimer's disease patients
    Corzo, L
    Fernandez-Novoa, L
    Zas, R
    Beyer, K
    Lao, JI
    Alvarez, XA
    Cacabelos, R
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 765 - 771
  • [22] Is beta-amyloid aggregation in Alzheimer's disease triggered by APOE4-mediated cerebrovascular dysfunction?
    Henderson, J.
    Anderle, S.
    Shaw, K.
    Trewhitt, H.
    Hall, C.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 232 - 232
  • [23] The association between APOE genotype and progression of Alzheimer's disease
    Tsolaki, M.
    Bosiki, M.
    Daniilidou, M.
    Pitsalidis, C. H.
    Molyva, D.
    Kounti, F.
    Papassotiropoulos, A.
    Kazis, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 58 - 58
  • [24] APOE genotype and survival in men and women with Alzheimer's disease
    Dal Forno, G
    Carson, KA
    Brookmeyer, R
    Troncoso, J
    Kawas, CH
    Brandt, J
    NEUROLOGY, 2002, 58 (07) : 1045 - 1050
  • [25] Serum lipoprotein profile and APOE genotype in Alzheimer's disease
    Cagnin, A.
    Zambon, A.
    Zarantonello, G.
    Vianello, D.
    Marchiori, M.
    Mercurio, D.
    Micciche, F.
    Ermani, M.
    Leon, A.
    Battistin, L.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2007, (72): : 175 - 179
  • [26] APOE genotype effects on alzheimer’s disease onset and epidemiology
    J. Wesson Ashford
    Journal of Molecular Neuroscience, 2004, 23 : 157 - 165
  • [27] Prediction of APOE genotype by phenotype in Alzheimer's disease.
    Todd, RD
    Ji, T
    Goate, AM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 81 (06): : 554 - 554
  • [28] The Association of Essential Metals with APOE Genotype in Alzheimer's Disease
    Leko, Mirjana Babic
    Jurasovic, Jasna
    Perkovic, Matea Nikolac
    Spanic, Ena
    Sekovanic, Ankica
    Orct, Tatjana
    Skudar, Vesna Lukinovic
    Baronica, Koraljka Bacic
    Kidemet-Piskac, Spomenka
    Vogrinc, Zeljka
    Pivac, Nela
    Borovecki, Fran
    Hof, Patrick R.
    Simic, Goran
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (02) : 661 - 672
  • [29] APOE genotype, lipids and risk for Alzheimer's disease in the Yoruba
    Ogunniyi, A
    Hall, KS
    Murrell, J
    Baiyewu, O
    Deeg, M
    Gureje, O
    Gao, S
    Unverzagt, FW
    Shen, J
    Smith-Gamble, V
    Dickson, J
    Hendrie, HC
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S296 - S296
  • [30] Phenotype of depression in Alzheimer's disease (AD) with APOE genotype
    Cantillon, M
    Barker, W
    Harwood, D
    Mullan, M
    Duara, R
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 546 - 546